Skip to main content
. 2012 Oct 15;2012:124215. doi: 10.1155/2012/124215

Table 1.

Demographic and clinical profile of study participants.

Diabetic subjects Nondiabetic subjects
AD CN AD CN
Number 25 261 30 125
Age (years) 78.6 (5.8)* 72.7 (5.6) 77.5 (6.3) 72.6 (4.6)
Female (%) 68.0* 50.2 80.0# 50.4
Education (years) 9.3 (2.0)* 11.9 (3.0) 11.0 (2.5) 12.5 (3.0)
BMI (kg/m2) 23.2 (4.6) 23.0 (3.4) 21.7 (2.2)# 23.6 (4.2)
Systolic blood pressure (mmHg) 127.0 (16.0) 130.0 (13.3) 126.6 (17.3) 128.6 (15.7)
Diastolic blood pressure (mmHg) 60.0 (15.1)* 70.0 (9.4) 58.5 (16.0)# 72.0 (9.0)
Total cholesterol (mg/dL) 197.8 (43.7) 206.1 (30.0) 214.4 (34.1) 196.1 (29.8)
Triglyceride (mg/dL) 118.9 (49.3) 157.4 (83.7) 131.0 (61.6) 109.8 (54.0)
HDL-cholesterol (mg/dL) 60.2 (12.5) 53.4 (14.7) 69.5 (18.6) 60.9 (17.9)
HbA1c (%) 7.1 (0.8) 7.2 (1.1)
Duration of diabetes (years) 16.6 (9.9) 14.6 (10.7)
Hypoglycemic episodes (times/year) 4.5 (13.0) 11.4 (47.2)
Insulin use (%) 40.0 30.3
Insulin dose (U/day) 17.0 (11.6) 22.7 (12.9)
Insulin injection (times/day) 2.4 (1.0) 2.4 (1.0)
Oral hypoglycemic agent use (yes = 1, no = 0) 0.8 (0.4) 0.7 (0.5)
Exercise (minutes/week) 72.3 (12.9)* 221.9 (468.7) 209.3 (161) 225.8 (208.7)
Diet therapy compliance (very poor = 1, poor = 2, normal = 3, good = 4) 3.2 (0.9) 3.3 (0.6) 3.3 (0.7) 3.4 (0.8)
History of heart disease (%) 4.0 19.9 3.7 20.0
History of cerebrovascular disease (%) 12.0 10.0 6.7 8.0
MMSE (score) 20.6 (3.8)* 28.0 (0.0) 20.8 (3.7)# 27.4 (2.1)
Computer-based screening test (score) 9.0 (2.9)* 14.3 (0.5) 9.9 (2.9)# 14.4 (0.5)

Values are the mean and (SD) and percentages. *P < 0.05 and # P < 0.05 compared with cognitively normal subjects in the diabetic and nondiabetic groups, respectively. AD: Alzheimer's disease; CN: cognitively normal; BMI: body mass index; MMSE: mini-mental state examination.